Back to Search
Start Over
Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells.
- Source :
-
Immune network [Immune Netw] 2022 Oct 24; Vol. 22 (6), pp. e50. Date of Electronic Publication: 2022 Oct 24 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Autoreactive B cells are not entirely deleted, but some remain as immunocompetent or anergic B cells. Although the persistence of autoreactive B cells as anergic cells has been shown in transgenic mouse models with the expression of B cell receptor (BCR) reactive to engineered self-antigen, the characterization of naturally occurring anergic B cells is important to identify them and understand their contribution to immune regulation or autoimmune diseases. We report here that a low-level expression of CD138 in the splenic B cells marks naturally arising anergic B cells, not plasma cells. The CD138 <superscript>int</superscript> B cells consisted of IgM <superscript>low</superscript> IgD <superscript>high</superscript> follicular (FO) B cells and transitional 3 B cells in homeostatic conditions. The CD138 <superscript>int</superscript> FO B cells showed an anergic gene expression profile shared with that of monoclonal anergic B cells expressing engineered BCRs and the gene expression profile was different from those of plasma cells, age-associated B cells, or germinal center B cells. The anergic state of the CD138 <superscript>int</superscript> FO B cells was confirmed by attenuated Ca <superscript>2+</superscript> response and failure to upregulate CD69 upon BCR engagement with anti-IgM, anti-IgD, anti-Igκ, or anti-IgG. The BCR repertoire of the CD138 <superscript>int</superscript> FO B cells was distinct from that of the CD138 <superscript>-</superscript> FO B cells and included some class-switched B cells with low-level somatic mutations. These findings demonstrate the presence of polyclonal anergic B cells in the normal mice that are characterized by low-level expression of CD138, IgM downregulation, reduced Ca <superscript>2+</superscript> and CD69 responses upon BCR engagement, and distinct BCR repertoire.<br />Competing Interests: Conflicts of Interest: The authors declare no potential conflicts of interest.<br /> (Copyright © 2022. The Korean Association of Immunologists.)
Details
- Language :
- English
- ISSN :
- 1598-2629
- Volume :
- 22
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Immune network
- Publication Type :
- Academic Journal
- Accession number :
- 36627940
- Full Text :
- https://doi.org/10.4110/in.2022.22.e50